Michael Dale joined Axogen Corporation as Chief Executive Officer ("CEO") and President, as well as a Board member, in August 2024. A distinguished healthcare leader and an accomplished medical device executive, Mr. Dale has over 35 years of experience leading transformative, high-technology medical device companies in the cardiovascular, neuromodulation, diabetes, and electrophysiology markets. His past executive leadership roles span both public and private medical device companies, including Abbott Structural Heart, GI Dynamics, Helical Solutions, ATS Medical, Endocardial Solutions, Cyberonics, St. Jude Medical, and American Edwards Laboratories. Mr. Dale has been an active director and advisor, serving on the boards of Preceptis Medical, Enpath Medical, Rhythmia Medical, Neuronetics, Inc., NeoChord, the Advanced Medical Technology Association (AdvaMed), the St. Mary s University Council of Regents for the School of Graduate and Professional Programs, and the University of Minnesota Carlson School of Management Medical Industry Leadership Institute. At present, he serves on the advisory board of Purdue University s Weldon School of Biomedical Engineering, and California Polytechnic State University s Center for Innovation & Entrepreneurship as Student Mentor. Mr. Dale holds a Bachelor of Science degree from California Polytechnic State University in San Luis Obispo, California.